Harms, Robbert L.
Ferrari, Alberto http://orcid.org/0000-0002-5939-8637
Meier, Irene B.
Martinkova, Julie
Santus, Enrico
Marino, Nicola
Cirillo, Davide
Mellino, Simona
Catuara Solarz, Silvina
Tarnanas, Ioannis
Szoeke, Cassandra
Hort, Jakub
Valencia, Alfonso
Ferretti, Maria Teresa
Seixas, Azizi
Santuccione Chadha, Antonella
Funding for this research was provided by:
Altoida Inc
Altoida Inc.
Grantová Agentura, Univerzita Karlova (436119)
Article History
Received: 15 February 2022
Accepted: 10 May 2022
First Online: 6 June 2022
Declarations
:
: The study was approved by the local institutional review board (IRB), i.e., New England IRB in San Diego, USA where the study was originally initiated.
: All patients have given written consent for their participation in this study.
: Not applicable.
: ES is Director of AI and Machine Learning at Bayer. A.S.C. is an official employee of Biogen International and works as Head of Stakeholder Engagement for Alzheimer disease at Biogen. She is also co-founder and CEO of the Women’s Brain Project.